Phenotypically and functionally unique CD86 expression CD8 T cell subset shapes immune regulation in the tumor...

Area of Science:

• Immunology
• Cancer Biology
• Cellular Immunology

Background:

• The tumor microenvironment (TME) utilizes regulatory immune programs to promote immune evasion.
• The precise identity, drivers, and function of CD8+ regulatory T cells within tumors are not fully understood.

Purpose of the Study:

• To define the phenotype, regulatory mechanisms, and function of CD86high CD8+ T cells in the context of tumor immunity.

Main Methods:

• Utilized murine tumor models, isolating tumor-infiltrating lymphocytes (TILs) for flow cytometry, RNA-seq, and functional co-cultures.
• Investigated upstream regulatory cues using cytokine stimulation and transcription factor analysis.
• Assessed in vivo function via conditional Cd86 knockout in CD8+ T cells.

Main Results:

• Identified a CD86high CD8+ T cell subset accumulating in tumors, exhibiting immunoregulatory and exhaustion programs.
• Established an IL-12-IRF5 axis controlling CD86 expression on these cells.
• Demonstrated that CD86high CD8+ T cells suppress antigen-specific responses and reprogram dendritic cells (DCs) towards a regulatory phenotype.
• Showed that ablating Cd86 in CD8+ T cells reduces tumor growth and promotes an immunostimulatory TME.

Conclusions:

• CD86high CD8+ T cells represent a distinct immunoregulatory subset in cancer, driven by the IL-12-IRF5 pathway.
• Their interaction with DCs via CD86/CTLA-4 promotes a tolerogenic TME.
• Targeting CD86 on CD8+ T cells offers a potential strategy to enhance anti-tumor immunity.